Clinical Trials Browser

OTHER × Pamidronate × Breast × Clear all

NCT04549207 2025-11-28

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Phase 4 Active not recruiting

Breast Neoplasms

NCT00128297 2023-03-28

Pamidronate Administration in Breast Cancer Patients With Bone Metastases

Phase 4 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT01907880 2017-07-07

ER11-03

Phase 4 Completed

Breast Neoplasms, Pain

NCT01067989 2015-07-08

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms, Neoplasm Metastasis